Haven't seen anything either re discontinuing LANI but would make sense if they lost BARDA funding. Too expensive and they have other drugs (Vapendavir) which they may be able to partner.
Seeking Alpha article:
http://seekingalpha.com/article/387...lts?li_source=LI&li_medium=liftigniter-widget
Full Analyst report with buy rating and $4.50 target price:
http://scr.zacks.com/News/Press-Rel...tiating-Coverage-on-Biota-Pharma/default.aspx
- Forums
- ASX - By Stock
- BTA
- LANI